• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN
June 9, 2017 11:10 AM EDT
Peer Review

Peer Re­view: J&J woos Mer­ck’s Math­ai Mam­men to helm of phar­ma R&D; Mer­ri­mack, Bay­er, and Ax­o­vant ex­pand lead­er­ship teams

Emma Yasinski

→ Mer­ri­mack ex­pand­ed its team with a new CMO and head of hu­man re­sources. The new CMO, Ser­gio San­til­lana comes from Ari­ad, and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

more like this

  • Sal­ly Sus­man waves good­bye to Pfiz­er; Xaira's new pres­i­dent and COO July 11, 2025
  • Now pri­vate, blue­bird bio con­tin­ues lead­er­ship re­vamp; Roche R&D ex­ec an­nounces re­tire­ment July 3, 2025
  • Bill Meury brings new per­spec­tive to In­cyte as Hop­penot re­tires; Ex-Mor­phoSys CEO leads re­vi­tal­ized Vor Bio June 27, 2025
TRENDING NOW

Sarep­ta adds black box warn­ing to its Duchenne treat­ment, cuts 500 work­ers

RFK reshuf­fles top HHS lead­er­ship, re­plac­ing his chief of staff and an­oth­er top aide

FDA drugs cen­ter sees sharp rise in staff de­par­tures since Jan­u­ary

Wear­able mak­er Whoop to fight FDA over blood pres­sure track­er

PureTech CEO leaves just one week af­ter long­time chair steps down

Bay­er ex­tends CEO Bill An­der­son­'s con­tract through March 2029

Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times